102 KiB
102 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 4 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 5 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 6 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 7 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 8 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||||
| 9 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.7 | 0 - 6.2 | umol/L | ||||||||||
| 10 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Alkaline Phosphatase | 57 | 40 - 129 | U/L | ||||||||||
| 11 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | ALT (SGPT) | 32 | 5 - 48 | U/L | ||||||||||
| 12 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | AST (SGOT) | 35 | 8 - 40 | U/L | ||||||||||
| 13 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | GGT | 14 | 10 - 61 | U/L | ||||||||||
| 14 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | LDH | 248 | H | 53 - 234 | U/L | |||||||||
| 15 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Urea Nitrogen | 8.2 | 1.4 - 8.6 | mmol/L | ||||||||||
| 16 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 97 | 40 - 110 | umol/L | ||||||||||
| 17 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Serum Glucose | 5.0 | 3.9 - 5.6 | mmol/L | ||||||||||
| 18 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Serum Uric Acid | 395 | 125 - 488 | umol/L | ||||||||||
| 19 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Calcium (EDTA) | 2.44 | 2.07 - 2.64 | mmol/L | ||||||||||
| 20 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Phosphorus | 1.19 | 0.71 - 1.65 | mmol/L | ||||||||||
| 21 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||||
| 22 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||||
| 23 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Creatine Kinase | 439 | H | 39 - 308 | U/L | |||||||||
| 24 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Serum Sodium | 137 | 132 - 147 | mmol/L | ||||||||||
| 25 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Serum Potassium | 4.6 | 3.5 - 5.2 | mmol/L | ||||||||||
| 26 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Serum Bicarbonate | 24.4 | 19.3 - 29.3 | mmol/L | ||||||||||
| 27 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||||
| 28 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CHEMISTRY PANEL | Magnesium | 0.77 | 0.66 - 1.07 | mmol/L | ||||||||||
| 29 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 88 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 30 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | FECAL COLLECTION D/T | Stool Collection Date | Y | 01-Jun-2026 | |||||||||||
| 31 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | FECAL COLLECTION D/T | Stool Collection Time | Y | 05:00 | |||||||||||
| 32 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 129 | 127 - 181 | g/L | ||||||||||
| 33 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.38 | L | 0.39 - 0.54 | ||||||||||
| 34 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | L | 4.5 - 6.4 | TI/L | |||||||||
| 35 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 36 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 37 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||||
| 38 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.82 | 3.8 - 10.7 | GI/L | ||||||||||
| 39 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.31 | 1.96 - 7.23 | GI/L | ||||||||||
| 40 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.93 | 0.91 - 4.28 | GI/L | ||||||||||
| 41 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.22 | 0.12 - 0.92 | GI/L | ||||||||||
| 42 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.32 | 0 - 0.57 | GI/L | ||||||||||
| 43 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||||
| 44 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 63.1 | 40.5 - 75 | % | ||||||||||
| 45 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 28.4 | 15.4 - 48.5 | % | ||||||||||
| 46 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 3.3 | 2.6 - 10.1 | % | ||||||||||
| 47 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.7 | 0 - 6.8 | % | ||||||||||
| 48 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||||
| 49 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 251 | 140 - 400 | GI/L | ||||||||||
| 50 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 51 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | LIPID PANEL | Direct HDL-C 4th Generation | 1.53 | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L | |||||||||
| 52 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | LIPID PANEL | Triglycerides (GPO) | 0.90 | 0.56 - 3.62 | mmol/L | ||||||||||
| 53 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | LIPID PANEL | Cholesterol (High Performance) | 5.18 | 3.88 - 6.83 | mmol/L | ||||||||||
| 54 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | LIPID PANEL | LDL Chol Friedewald 4th | 3.24 | 0 - 3.34 | mmol/L | ||||||||||
| 55 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 56 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 01-Jun-2026 | |||||||||||
| 57 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 14:55 | |||||||||||
| 58 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 01-Jun-2026 | |||||||||||
| 59 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 16:05 | |||||||||||
| 60 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 01-Jun-2026 | |||||||||||
| 61 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 14:55 | |||||||||||
| 62 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 01-Jun-2026 | |||||||||||
| 63 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 05:00 | |||||||||||
| 64 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 01-Jun-2026 | |||||||||||
| 65 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 05:00 | |||||||||||
| 66 | CZ100222003 | Male | Induction Week 12 | Jun 1, 2026 2:55 PM | 6228137355 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 67 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 68 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 69 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 70 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 20-May-2026 | |||||||||||
| 71 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 11:44 | |||||||||||
| 72 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 73 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 74 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 75 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 76 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 22-May-2026 | ||||||||||||
| 77 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 78 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 79 | CZ100222003 | Male | Biopsy | May 20, 2026 12:00 AM | 6228179945 | ULCERATED AREA | Is biopsy site ulcerated? | Yes | ||||||||||||
| 80 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 81 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 82 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 83 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 84 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 85 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Total Bilirubin | 11 | 3 - 21 | umol/L | ||||||||||
| 86 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.5 | 0 - 6.2 | umol/L | ||||||||||
| 87 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Alkaline Phosphatase | 68 | 40 - 129 | U/L | ||||||||||
| 88 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | ALT (SGPT) | 10 | 5 - 48 | U/L | ||||||||||
| 89 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||||
| 90 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | GGT | 10 | 10 - 61 | U/L | ||||||||||
| 91 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | LDH | 164 | 53 - 234 | U/L | ||||||||||
| 92 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Urea Nitrogen | 5.1 | 1.4 - 8.6 | mmol/L | ||||||||||
| 93 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 101 | 40 - 110 | umol/L | ||||||||||
| 94 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Serum Glucose | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||||
| 95 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Serum Uric Acid | 255 | 125 - 488 | umol/L | ||||||||||
| 96 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Calcium (EDTA) | 2.45 | 2.07 - 2.64 | mmol/L | ||||||||||
| 97 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Phosphorus | 1.10 | 0.71 - 1.65 | mmol/L | ||||||||||
| 98 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Total Protein | 66 | 61 - 84 | g/L | ||||||||||
| 99 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||||
| 100 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Creatine Kinase | 131 | 39 - 308 | U/L | ||||||||||
| 101 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | ||||||||||
| 102 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||||
| 103 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Serum Bicarbonate | 25.4 | 19.3 - 29.3 | mmol/L | ||||||||||
| 104 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Serum Chloride | 105 | 94 - 112 | mmol/L | ||||||||||
| 105 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CHEMISTRY PANEL | Magnesium | 0.82 | 0.66 - 1.07 | mmol/L | ||||||||||
| 106 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 87 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 107 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | FECAL COLLECTION D/T | Stool Collection Date | Y | 05-May-2026 | |||||||||||
| 108 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:40 | |||||||||||
| 109 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 145 | 127 - 181 | g/L | ||||||||||
| 110 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.39 - 0.54 | |||||||||||
| 111 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.8 | 4.5 - 6.4 | TI/L | ||||||||||
| 112 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 113 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 114 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||||
| 115 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.72 | 3.8 - 10.7 | GI/L | ||||||||||
| 116 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.17 | 1.96 - 7.23 | GI/L | ||||||||||
| 117 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.71 | 0.91 - 4.28 | GI/L | ||||||||||
| 118 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.36 | 0.12 - 0.92 | GI/L | ||||||||||
| 119 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.44 | 0 - 0.57 | GI/L | ||||||||||
| 120 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||||
| 121 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 55.4 | 40.5 - 75 | % | ||||||||||
| 122 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 30.0 | 15.4 - 48.5 | % | ||||||||||
| 123 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.3 | 2.6 - 10.1 | % | ||||||||||
| 124 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 7.7 | H | 0 - 6.8 | % | |||||||||
| 125 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||||
| 126 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 294 | 140 - 400 | GI/L | ||||||||||
| 127 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 128 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 05-May-2026 | |||||||||||
| 129 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 07:40 | |||||||||||
| 130 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 05-May-2026 | |||||||||||
| 131 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 08:50 | |||||||||||
| 132 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 05-May-2026 | |||||||||||
| 133 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 07:40 | |||||||||||
| 134 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 05-May-2026 | |||||||||||
| 135 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 06:40 | |||||||||||
| 136 | CZ100222005 | Male | Induction Week 4 | May 5, 2026 7:40 AM | 6228179936 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 137 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 138 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 139 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 140 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 141 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 142 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||||
| 143 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.1 | 0 - 6.2 | umol/L | ||||||||||
| 144 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Alkaline Phosphatase | 65 | 40 - 129 | U/L | ||||||||||
| 145 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | ALT (SGPT) | 7 | 5 - 48 | U/L | ||||||||||
| 146 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||||
| 147 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | GGT | 7 | L | 10 - 61 | U/L | |||||||||
| 148 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | LDH | 147 | 53 - 234 | U/L | ||||||||||
| 149 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Urea Nitrogen | 5.2 | 1.4 - 8.6 | mmol/L | ||||||||||
| 150 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 88 | 40 - 110 | umol/L | ||||||||||
| 151 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Serum Glucose | 4.5 | 3.9 - 5.6 | mmol/L | ||||||||||
| 152 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Serum Uric Acid | 261 | 125 - 488 | umol/L | ||||||||||
| 153 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Calcium (EDTA) | 2.31 | 2.07 - 2.64 | mmol/L | ||||||||||
| 154 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Phosphorus | 1.13 | 0.71 - 1.65 | mmol/L | ||||||||||
| 155 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Total Protein | 65 | 61 - 84 | g/L | ||||||||||
| 156 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Albumin-BCG | 41 | 33 - 49 | g/L | ||||||||||
| 157 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Creatine Kinase | 112 | 39 - 308 | U/L | ||||||||||
| 158 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 159 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | ||||||||||
| 160 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Serum Bicarbonate | 23.2 | 19.3 - 29.3 | mmol/L | ||||||||||
| 161 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||||
| 162 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CHEMISTRY PANEL | Magnesium | 0.76 | 0.66 - 1.07 | mmol/L | ||||||||||
| 163 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 102 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 164 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | FECAL COLLECTION D/T | Stool Collection Date | Y | 22-Apr-2026 | |||||||||||
| 165 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | FECAL COLLECTION D/T | Stool Collection Time | Y | 05:40 | |||||||||||
| 166 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 143 | 127 - 181 | g/L | ||||||||||
| 167 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.41 | 0.39 - 0.54 | |||||||||||
| 168 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.8 | 4.5 - 6.4 | TI/L | ||||||||||
| 169 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 170 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 171 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||||
| 172 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.68 | 3.8 - 10.7 | GI/L | ||||||||||
| 173 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.92 | 1.96 - 7.23 | GI/L | ||||||||||
| 174 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.94 | 0.91 - 4.28 | GI/L | ||||||||||
| 175 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.39 | 0.12 - 0.92 | GI/L | ||||||||||
| 176 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.40 | 0 - 0.57 | GI/L | ||||||||||
| 177 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||||
| 178 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 58.7 | 40.5 - 75 | % | ||||||||||
| 179 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.0 | 15.4 - 48.5 | % | ||||||||||
| 180 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.9 | 2.6 - 10.1 | % | ||||||||||
| 181 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 5.9 | 0 - 6.8 | % | ||||||||||
| 182 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||||
| 183 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 308 | 140 - 400 | GI/L | ||||||||||
| 184 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 185 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 22-Apr-2026 | |||||||||||
| 186 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 14:15 | |||||||||||
| 187 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 22-Apr-2026 | |||||||||||
| 188 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 15:25 | |||||||||||
| 189 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 22-Apr-2026 | |||||||||||
| 190 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 14:15 | |||||||||||
| 191 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 22-Apr-2026 | |||||||||||
| 192 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 05:40 | |||||||||||
| 193 | CZ100222005 | Male | Induction Week 2 | Apr 22, 2026 2:15 PM | 6228179932 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 194 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||||
| 195 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.2 | 0 - 6.2 | umol/L | ||||||||||
| 196 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Alkaline Phosphatase | 71 | 40 - 129 | U/L | ||||||||||
| 197 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | ALT (SGPT) | 7 | 5 - 48 | U/L | ||||||||||
| 198 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | AST (SGOT) | 16 | 8 - 40 | U/L | ||||||||||
| 199 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | GGT | 7 | L | 10 - 61 | U/L | |||||||||
| 200 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | LDH | 153 | 53 - 234 | U/L | ||||||||||
| 201 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Urea Nitrogen | 4.9 | 1.4 - 8.6 | mmol/L | ||||||||||
| 202 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 86 | 40 - 110 | umol/L | ||||||||||
| 203 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Serum Glucose | 4.2 | 3.9 - 5.6 | mmol/L | ||||||||||
| 204 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Serum Uric Acid | 299 | 125 - 488 | umol/L | ||||||||||
| 205 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Calcium (EDTA) | 2.35 | 2.07 - 2.64 | mmol/L | ||||||||||
| 206 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Phosphorus | 1.05 | 0.71 - 1.65 | mmol/L | ||||||||||
| 207 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Total Protein | 68 | 61 - 84 | g/L | ||||||||||
| 208 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||||
| 209 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Creatine Kinase | 116 | 39 - 308 | U/L | ||||||||||
| 210 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||||
| 211 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | ||||||||||
| 212 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Serum Bicarbonate | 23.9 | 19.3 - 29.3 | mmol/L | ||||||||||
| 213 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||||
| 214 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CHEMISTRY PANEL | Magnesium | 0.80 | 0.66 - 1.07 | mmol/L | ||||||||||
| 215 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 106 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 216 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | FECAL COLLECTION D/T | Stool Collection Date | Y | 09-Apr-2026 | |||||||||||
| 217 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | FECAL COLLECTION D/T | Stool Collection Time | Y | 05:55 | |||||||||||
| 218 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 146 | 127 - 181 | g/L | ||||||||||
| 219 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.39 - 0.54 | |||||||||||
| 220 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||||
| 221 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 222 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 223 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||||
| 224 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.07 | 3.8 - 10.7 | GI/L | ||||||||||
| 225 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.83 | 1.96 - 7.23 | GI/L | ||||||||||
| 226 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.67 | 0.91 - 4.28 | GI/L | ||||||||||
| 227 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.32 | 0.12 - 0.92 | GI/L | ||||||||||
| 228 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.19 | 0 - 0.57 | GI/L | ||||||||||
| 229 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||||
| 230 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 63.1 | 40.5 - 75 | % | ||||||||||
| 231 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.6 | 15.4 - 48.5 | % | ||||||||||
| 232 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.2 | 2.6 - 10.1 | % | ||||||||||
| 233 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.2 | 0 - 6.8 | % | ||||||||||
| 234 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.8 | 0 - 2 | % | ||||||||||
| 235 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 314 | 140 - 400 | GI/L | ||||||||||
| 236 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 237 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | LIPID PANEL | Direct HDL-C 4th Generation | 1.90 | H | 1.03 - 1.53 | mmol/L | |||||||||
| 238 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | LIPID PANEL | Triglycerides (GPO) | 0.43 | L | 0.56 - 3.62 | mmol/L | |||||||||
| 239 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | LIPID PANEL | Cholesterol (High Performance) | 3.22 | L | 3.88 - 6.83 | mmol/L | |||||||||
| 240 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | LIPID PANEL | LDL Chol Friedewald 4th | 1.12 | 0 - 3.34 | mmol/L | ||||||||||
| 241 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 242 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 09-Apr-2026 | |||||||||||
| 243 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 10:35 | |||||||||||
| 244 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 09-Apr-2026 | |||||||||||
| 245 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 11:45 | |||||||||||
| 246 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 09-Apr-2026 | |||||||||||
| 247 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 10:35 | |||||||||||
| 248 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 09-Apr-2026 | |||||||||||
| 249 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 05:55 | |||||||||||
| 250 | CZ100222005 | Male | Induction Week 0 | Apr 9, 2026 10:35 AM | 6228173397 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 251 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 252 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 253 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 254 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 255 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 256 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||||
| 257 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.9 | 0 - 6.2 | umol/L | ||||||||||
| 258 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Alkaline Phosphatase | 64 | 40 - 129 | U/L | ||||||||||
| 259 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | ALT (SGPT) | 42 | 5 - 48 | U/L | ||||||||||
| 260 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | AST (SGOT) | 31 | 8 - 40 | U/L | ||||||||||
| 261 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | GGT | 24 | 10 - 61 | U/L | ||||||||||
| 262 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | LDH | 225 | 53 - 234 | U/L | ||||||||||
| 263 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Urea Nitrogen | 10.1 | H | 1.4 - 8.6 | mmol/L | |||||||||
| 264 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 110 | 40 - 110 | umol/L | ||||||||||
| 265 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Serum Glucose | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||||
| 266 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Serum Uric Acid | 455 | 125 - 488 | umol/L | ||||||||||
| 267 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Calcium (EDTA) | 2.42 | 2.07 - 2.64 | mmol/L | ||||||||||
| 268 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Phosphorus | 1.20 | 0.71 - 1.65 | mmol/L | ||||||||||
| 269 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||||
| 270 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||||
| 271 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Creatine Kinase | 367 | H | 39 - 308 | U/L | |||||||||
| 272 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 273 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 274 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Serum Bicarbonate | 24.7 | 19.3 - 29.3 | mmol/L | ||||||||||
| 275 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||||
| 276 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CHEMISTRY PANEL | Magnesium | 0.77 | 0.66 - 1.07 | mmol/L | ||||||||||
| 277 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 76 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 278 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | FECAL COLLECTION D/T | Stool Collection Date | Y | 08-Apr-2026 | |||||||||||
| 279 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | FECAL COLLECTION D/T | Stool Collection Time | Y | 05:15 | |||||||||||
| 280 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 135 | 127 - 181 | g/L | ||||||||||
| 281 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.39 - 0.54 | |||||||||||
| 282 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.5 - 6.4 | TI/L | ||||||||||
| 283 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 29 | 26 - 34 | pg | ||||||||||
| 284 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 285 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 85 | 79 - 96 | fL | ||||||||||
| 286 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.70 | 3.8 - 10.7 | GI/L | ||||||||||
| 287 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.33 | 1.96 - 7.23 | GI/L | ||||||||||
| 288 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.26 | 0.91 - 4.28 | GI/L | ||||||||||
| 289 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | ||||||||||
| 290 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.67 | R | H | 0 - 0.57 | GI/L | ||||||||
| 291 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||||
| 292 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 40.8 | 40.5 - 75 | % | ||||||||||
| 293 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 39.6 | 15.4 - 48.5 | % | ||||||||||
| 294 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.0 | 2.6 - 10.1 | % | ||||||||||
| 295 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 11.7 | R | H | 0 - 6.8 | % | ||||||||
| 296 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.9 | 0 - 2 | % | ||||||||||
| 297 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 282 | 140 - 400 | GI/L | ||||||||||
| 298 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 299 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 08-Apr-2026 | |||||||||||
| 300 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 08:05 | |||||||||||
| 301 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 08-Apr-2026 | |||||||||||
| 302 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 09:15 | |||||||||||
| 303 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 08-Apr-2026 | |||||||||||
| 304 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 08:05 | |||||||||||
| 305 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 08-Apr-2026 | |||||||||||
| 306 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 05:15 | |||||||||||
| 307 | CZ100222003 | Male | Induction Week 4 | Apr 8, 2026 8:05 AM | 6227323274 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 308 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 309 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 310 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 311 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 01-Apr-2026 | |||||||||||
| 312 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 08:46 | |||||||||||
| 313 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 314 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 315 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 316 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 317 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 03-Apr-2026 | ||||||||||||
| 318 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 319 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 320 | CZ100222005 | Male | Biopsy | Apr 1, 2026 12:00 AM | 6228023951 | ULCERATED AREA | Is biopsy site ulcerated? | No | ||||||||||||
| 321 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 322 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 323 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 324 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 325 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 326 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||||
| 327 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | <1.4 | 0 - 6.2 | umol/L | ||||||||||
| 328 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Alkaline Phosphatase | 58 | 40 - 129 | U/L | ||||||||||
| 329 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | ALT (SGPT) | 26 | 5 - 48 | U/L | ||||||||||
| 330 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||||
| 331 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | GGT | 14 | 10 - 61 | U/L | ||||||||||
| 332 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | LDH | 170 | 53 - 234 | U/L | ||||||||||
| 333 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Urea Nitrogen | 9.4 | R | H | 1.4 - 8.6 | mmol/L | ||||||||
| 334 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 104 | 40 - 110 | umol/L | ||||||||||
| 335 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Serum Glucose | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||||
| 336 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Serum Uric Acid | 353 | 125 - 488 | umol/L | ||||||||||
| 337 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Calcium (EDTA) | 2.36 | 2.07 - 2.64 | mmol/L | ||||||||||
| 338 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Phosphorus | 1.32 | 0.71 - 1.65 | mmol/L | ||||||||||
| 339 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Total Protein | 68 | 61 - 84 | g/L | ||||||||||
| 340 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Albumin-BCG | 42 | 33 - 49 | g/L | ||||||||||
| 341 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Creatine Kinase | 167 | 39 - 308 | U/L | ||||||||||
| 342 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||||
| 343 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||||
| 344 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Serum Bicarbonate | 23.9 | 19.3 - 29.3 | mmol/L | ||||||||||
| 345 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Serum Chloride | 105 | 94 - 112 | mmol/L | ||||||||||
| 346 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CHEMISTRY PANEL | Magnesium | 0.73 | 0.66 - 1.07 | mmol/L | ||||||||||
| 347 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 80 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 348 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | FECAL COLLECTION D/T | Stool Collection Date | Y | 27-Mar-2026 | |||||||||||
| 349 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | FECAL COLLECTION D/T | Stool Collection Time | Y | 05:40 | |||||||||||
| 350 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 133 | 127 - 181 | g/L | ||||||||||
| 351 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.39 - 0.54 | |||||||||||
| 352 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.5 - 6.4 | TI/L | ||||||||||
| 353 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 29 | 26 - 34 | pg | ||||||||||
| 354 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 355 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||||
| 356 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.92 | 3.8 - 10.7 | GI/L | ||||||||||
| 357 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.29 | 1.96 - 7.23 | GI/L | ||||||||||
| 358 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.57 | 0.91 - 4.28 | GI/L | ||||||||||
| 359 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.41 | 0.12 - 0.92 | GI/L | ||||||||||
| 360 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.61 | R | H | 0 - 0.57 | GI/L | ||||||||
| 361 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||||
| 362 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 38.7 | R | L | 40.5 - 75 | % | ||||||||
| 363 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 43.4 | 15.4 - 48.5 | % | ||||||||||
| 364 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.9 | 2.6 - 10.1 | % | ||||||||||
| 365 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 10.3 | R | H | 0 - 6.8 | % | ||||||||
| 366 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||||
| 367 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 252 | 140 - 400 | GI/L | ||||||||||
| 368 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 369 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 27-Mar-2026 | |||||||||||
| 370 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 07:10 | |||||||||||
| 371 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 27-Mar-2026 | |||||||||||
| 372 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 08:20 | |||||||||||
| 373 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 27-Mar-2026 | |||||||||||
| 374 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 07:10 | |||||||||||
| 375 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 27-Mar-2026 | |||||||||||
| 376 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 05:40 | |||||||||||
| 377 | CZ100222003 | Male | Induction Week 2 | Mar 27, 2026 7:10 AM | 6227323272 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 378 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Total Bilirubin | 3 | Result verified by repeat analysis | 3 - 21 | umol/L | ||||||||
| 379 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | <1.4 | Result verified by repeat analysis | 0 - 6.2 | umol/L | ||||||||
| 380 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Alkaline Phosphatase | 85 | 40 - 129 | U/L | |||||||||
| 381 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | ALT (SGPT) | 20 | 5 - 48 | U/L | |||||||||
| 382 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | AST (SGOT) | 15 | 8 - 40 | U/L | |||||||||
| 383 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | GGT | 19 | 10 - 50 | U/L | |||||||||
| 384 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | LDH | Test cancelled: Hemolysis-test not performed | |||||||||||
| 385 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Urea Nitrogen | 5.5 | 1.4 - 8.6 | mmol/L | |||||||||
| 386 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 108 | 40 - 119 | umol/L | |||||||||
| 387 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Serum Glucose | 4.9 | 3.9 - 5.6 | mmol/L | |||||||||
| 388 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Serum Uric Acid | 429 | 149 - 494 | umol/L | |||||||||
| 389 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Calcium (EDTA) | 2.07 | 2.07 - 2.64 | mmol/L | |||||||||
| 390 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Phosphorus | 1.02 | 0.71 - 1.65 | mmol/L | |||||||||
| 391 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Total Protein | 55 | L | 60 - 80 | g/L | ||||||||
| 392 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Albumin-BCG | 35 | 33 - 49 | g/L | |||||||||
| 393 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Creatine Kinase | 49 | 39 - 308 | U/L | |||||||||
| 394 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Serum Sodium | 148 | H | 135 - 145 | mmol/L | ||||||||
| 395 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | |||||||||
| 396 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Serum Bicarbonate | 24.4 | 19.3 - 29.3 | mmol/L | |||||||||
| 397 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Serum Chloride | 110 | 94 - 112 | mmol/L | |||||||||
| 398 | CZ100222004 | Male | Unscheduled | R | Mar 13, 2026 8:40 AM | 6227323295 | CHEMISTRY PANEL | Magnesium | 0.82 | 0.66 - 0.98 | mmol/L | |||||||||
| 399 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | |||||||||
| 400 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.2 | 0 - 6.2 | umol/L | |||||||||
| 401 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Alkaline Phosphatase | 73 | 40 - 129 | U/L | |||||||||
| 402 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | ALT (SGPT) | 5 | 5 - 48 | U/L | |||||||||
| 403 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | AST (SGOT) | 15 | 8 - 40 | U/L | |||||||||
| 404 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | GGT | 6 | R | L | 10 - 61 | U/L | |||||||
| 405 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | LDH | 149 | 53 - 234 | U/L | |||||||||
| 406 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Urea Nitrogen | 3.8 | 1.4 - 8.6 | mmol/L | |||||||||
| 407 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 91 | 40 - 110 | umol/L | |||||||||
| 408 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Serum Glucose | 4.6 | 3.9 - 5.6 | mmol/L | |||||||||
| 409 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Serum Uric Acid | 277 | 125 - 488 | umol/L | |||||||||
| 410 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Calcium (EDTA) | 2.42 | 2.07 - 2.64 | mmol/L | |||||||||
| 411 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Phosphorus | 1.23 | 0.71 - 1.65 | mmol/L | |||||||||
| 412 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Total Protein | 68 | 61 - 84 | g/L | |||||||||
| 413 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | |||||||||
| 414 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Creatine Kinase | 119 | 39 - 308 | U/L | |||||||||
| 415 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | |||||||||
| 416 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | |||||||||
| 417 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Serum Bicarbonate | 27.4 | 19.3 - 29.3 | mmol/L | |||||||||
| 418 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | |||||||||
| 419 | CZ100222005 | Male | Unscheduled | R | Mar 13, 2026 7:45 AM | 6227323297 | CHEMISTRY PANEL | Magnesium | 0.81 | 0.66 - 1.07 | mmol/L | |||||||||
| 420 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||||
| 421 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.7 | 0 - 6.2 | umol/L | ||||||||||
| 422 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Alkaline Phosphatase | 91 | 40 - 129 | U/L | ||||||||||
| 423 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | ALT (SGPT) | 79 | R | H | 5 - 48 | U/L | ||||||||
| 424 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | AST (SGOT) | 51 | R | H | 8 - 40 | U/L | ||||||||
| 425 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | GGT | 45 | 10 - 61 | U/L | ||||||||||
| 426 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | LDH | 228 | 53 - 234 | U/L | ||||||||||
| 427 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Urea Nitrogen | 8.3 | 1.4 - 8.6 | mmol/L | ||||||||||
| 428 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 106 | 40 - 110 | umol/L | ||||||||||
| 429 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Serum Glucose | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||||
| 430 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Serum Uric Acid | 418 | 125 - 488 | umol/L | ||||||||||
| 431 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Calcium (EDTA) | 2.32 | 2.07 - 2.64 | mmol/L | ||||||||||
| 432 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Phosphorus | 1.10 | 0.71 - 1.65 | mmol/L | ||||||||||
| 433 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Total Protein | 68 | 61 - 84 | g/L | ||||||||||
| 434 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Albumin-BCG | 41 | 33 - 49 | g/L | ||||||||||
| 435 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Creatine Kinase | 250 | 39 - 308 | U/L | ||||||||||
| 436 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 437 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||||
| 438 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Serum Bicarbonate | 25.4 | 19.3 - 29.3 | mmol/L | ||||||||||
| 439 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||||
| 440 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CHEMISTRY PANEL | Magnesium | 0.73 | 0.66 - 1.07 | mmol/L | ||||||||||
| 441 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 79 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 442 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | FECAL COLLECTION D/T | Stool Collection Date | Y | 09-Mar-2026 | |||||||||||
| 443 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | FECAL COLLECTION D/T | Stool Collection Time | Y | 08:55 | |||||||||||
| 444 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 134 | 127 - 181 | g/L | ||||||||||
| 445 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.39 - 0.54 | |||||||||||
| 446 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.5 - 6.4 | TI/L | ||||||||||
| 447 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 448 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Normocytic | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 449 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | ||||||||||
| 450 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.70 | 3.8 - 10.7 | GI/L | ||||||||||
| 451 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.17 | 1.96 - 7.23 | GI/L | ||||||||||
| 452 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.01 | 0.91 - 4.28 | GI/L | ||||||||||
| 453 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.39 | 0.12 - 0.92 | GI/L | ||||||||||
| 454 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 1.08 | R | H | 0 - 0.57 | GI/L | ||||||||
| 455 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||||
| 456 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 47.4 | 40.5 - 75 | % | ||||||||||
| 457 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.9 | 15.4 - 48.5 | % | ||||||||||
| 458 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.8 | 2.6 - 10.1 | % | ||||||||||
| 459 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 16.1 | R | H | 0 - 6.8 | % | ||||||||
| 460 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.8 | 0 - 2 | % | ||||||||||
| 461 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 262 | 140 - 400 | GI/L | ||||||||||
| 462 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 463 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | LIPID PANEL | Direct HDL-C 4th Generation | 1.13 | 1.03 - 1.53 | mmol/L | ||||||||||
| 464 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | LIPID PANEL | Triglycerides (GPO) | 0.84 | 0.56 - 3.62 | mmol/L | ||||||||||
| 465 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | LIPID PANEL | Cholesterol (High Performance) | 5.14 | 3.88 - 6.83 | mmol/L | ||||||||||
| 466 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | LIPID PANEL | LDL Chol Friedewald 4th | 3.63 | H | 0 - 3.34 | mmol/L | |||||||||
| 467 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 468 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 09-Mar-2026 | |||||||||||
| 469 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 08:50 | |||||||||||
| 470 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 09-Mar-2026 | |||||||||||
| 471 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 10:05 | |||||||||||
| 472 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 09-Mar-2026 | |||||||||||
| 473 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 08:50 | |||||||||||
| 474 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 09-Mar-2026 | |||||||||||
| 475 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 08:55 | |||||||||||
| 476 | CZ100222003 | Male | Induction Week 0 | Mar 9, 2026 8:50 AM | 6227323270 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 190 | cm | ||||||||||
| 477 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Total Bilirubin | Test group cancelled: No specimen received | ||||||||||||
| 478 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | Test group cancelled: No specimen received | ||||||||||||
| 479 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Alkaline Phosphatase | Test group cancelled: No specimen received | ||||||||||||
| 480 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | ALT (SGPT) | Test group cancelled: No specimen received | ||||||||||||
| 481 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | AST (SGOT) | Test group cancelled: No specimen received | ||||||||||||
| 482 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | GGT | Test group cancelled: No specimen received | ||||||||||||
| 483 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | LDH | Test group cancelled: No specimen received | ||||||||||||
| 484 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Urea Nitrogen | Test group cancelled: No specimen received | ||||||||||||
| 485 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | Test group cancelled: No specimen received | ||||||||||||
| 486 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Serum Glucose | Test group cancelled: No specimen received | ||||||||||||
| 487 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Serum Uric Acid | Test group cancelled: No specimen received | ||||||||||||
| 488 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Calcium (EDTA) | Test group cancelled: No specimen received | ||||||||||||
| 489 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Phosphorus | Test group cancelled: No specimen received | ||||||||||||
| 490 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Total Protein | Test group cancelled: No specimen received | ||||||||||||
| 491 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Albumin-BCG | Test group cancelled: No specimen received | ||||||||||||
| 492 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Creatine Kinase | Test group cancelled: No specimen received | ||||||||||||
| 493 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Serum Sodium | Test group cancelled: No specimen received | ||||||||||||
| 494 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Serum Potassium | Test group cancelled: No specimen received | ||||||||||||
| 495 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Serum Bicarbonate | Test group cancelled: No specimen received | ||||||||||||
| 496 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Serum Chloride | Test group cancelled: No specimen received | ||||||||||||
| 497 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | CHEMISTRY PANEL | Magnesium | Test group cancelled: No specimen received | ||||||||||||
| 498 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 499 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 148 | 127 - 181 | g/L | ||||||||||
| 500 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||||
| 501 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||||
| 502 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 503 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 504 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 96 | fL | ||||||||||
| 505 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.67 | 3.8 - 10.7 | GI/L | ||||||||||
| 506 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.96 | 1.96 - 7.23 | GI/L | ||||||||||
| 507 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.68 | 0.91 - 4.28 | GI/L | ||||||||||
| 508 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.51 | 0.12 - 0.92 | GI/L | ||||||||||
| 509 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.42 | 0 - 0.57 | GI/L | ||||||||||
| 510 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.10 | 0 - 0.2 | GI/L | ||||||||||
| 511 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.3 | 40.5 - 75 | % | ||||||||||
| 512 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 25.2 | 15.4 - 48.5 | % | ||||||||||
| 513 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.7 | 2.6 - 10.1 | % | ||||||||||
| 514 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 6.3 | 0 - 6.8 | % | ||||||||||
| 515 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.5 | 0 - 2 | % | ||||||||||
| 516 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 341 | 140 - 400 | GI/L | ||||||||||
| 517 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 518 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Reactive | Ref Rng :$Non Reactive | |||||||||||
| 519 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 520 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 521 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 522 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 523 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 524 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 525 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 526 | CZ100222005 | Male | Screening | Mar 4, 2026 9:20 AM | 6227810900 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 188 | cm | ||||||||||
| 527 | CZ100222005 | Male | Stool Pathogens | Mar 4, 2026 9:10 AM | 6227810904 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 528 | CZ100222005 | Male | Stool Pathogens | Mar 4, 2026 9:10 AM | 6227810904 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 529 | CZ100222005 | Male | Stool Pathogens | Mar 4, 2026 9:10 AM | 6227810904 | OVA AND PARASITES 1 | Concentrate Exam | Test group cancelled: No specimen received | ||||||||||||
| 530 | CZ100222005 | Male | Stool Pathogens | Mar 4, 2026 9:10 AM | 6227810904 | OVA AND PARASITES 1 | Smear for Microsporidia | Test group cancelled: No specimen received | ||||||||||||
| 531 | CZ100222005 | Male | Stool Pathogens | Mar 4, 2026 9:10 AM | 6227810904 | OVA AND PARASITES 1 | Modified acid-fast stain | Test group cancelled: No specimen received | ||||||||||||
| 532 | CZ100222005 | Male | Stool Pathogens | Mar 4, 2026 9:10 AM | 6227810904 | OVA AND PARASITES 2 | Trichrome Smear | Test group cancelled: No specimen received | ||||||||||||
| 533 | CZ100222004 | Male | Stool Pathogens | Mar 3, 2026 12:20 PM | 6227810905 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 534 | CZ100222004 | Male | Stool Pathogens | Mar 3, 2026 12:20 PM | 6227810905 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 535 | CZ100222004 | Male | Stool Pathogens | Mar 3, 2026 12:20 PM | 6227810905 | OVA AND PARASITES 1 | Concentrate Exam | Test group cancelled: No specimen received | ||||||||||||
| 536 | CZ100222004 | Male | Stool Pathogens | Mar 3, 2026 12:20 PM | 6227810905 | OVA AND PARASITES 1 | Smear for Microsporidia | Test group cancelled: No specimen received | ||||||||||||
| 537 | CZ100222004 | Male | Stool Pathogens | Mar 3, 2026 12:20 PM | 6227810905 | OVA AND PARASITES 1 | Modified acid-fast stain | Test group cancelled: No specimen received | ||||||||||||
| 538 | CZ100222004 | Male | Stool Pathogens | Mar 3, 2026 12:20 PM | 6227810905 | OVA AND PARASITES 2 | Trichrome Smear | Test group cancelled: No specimen received | ||||||||||||
| 539 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Total Bilirubin | Test group cancelled: No specimen received | ||||||||||||
| 540 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | Test group cancelled: No specimen received | ||||||||||||
| 541 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Alkaline Phosphatase | Test group cancelled: No specimen received | ||||||||||||
| 542 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | ALT (SGPT) | Test group cancelled: No specimen received | ||||||||||||
| 543 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | AST (SGOT) | Test group cancelled: No specimen received | ||||||||||||
| 544 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | GGT | Test group cancelled: No specimen received | ||||||||||||
| 545 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | LDH | Test group cancelled: No specimen received | ||||||||||||
| 546 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Urea Nitrogen | Test group cancelled: No specimen received | ||||||||||||
| 547 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | Test group cancelled: No specimen received | ||||||||||||
| 548 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Serum Glucose | Test group cancelled: No specimen received | ||||||||||||
| 549 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Serum Uric Acid | Test group cancelled: No specimen received | ||||||||||||
| 550 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Calcium (EDTA) | Test group cancelled: No specimen received | ||||||||||||
| 551 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Phosphorus | Test group cancelled: No specimen received | ||||||||||||
| 552 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Total Protein | Test group cancelled: No specimen received | ||||||||||||
| 553 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Albumin-BCG | Test group cancelled: No specimen received | ||||||||||||
| 554 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Creatine Kinase | Test group cancelled: No specimen received | ||||||||||||
| 555 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Serum Sodium | Test group cancelled: No specimen received | ||||||||||||
| 556 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Serum Potassium | Test group cancelled: No specimen received | ||||||||||||
| 557 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Serum Bicarbonate | Test group cancelled: No specimen received | ||||||||||||
| 558 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Serum Chloride | Test group cancelled: No specimen received | ||||||||||||
| 559 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CHEMISTRY PANEL | Magnesium | Test group cancelled: No specimen received | ||||||||||||
| 560 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | Test group cancelled: No specimen received | ||||||||||||
| 561 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 562 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 91 | L | 125 - 170 | g/L | |||||||||
| 563 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.31 | L | 0.37 - 0.51 | ||||||||||
| 564 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 3.7 | L | 4 - 5.8 | TI/L | |||||||||
| 565 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 25 | L | 26 - 34 | pg | |||||||||
| 566 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 567 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 80 - 100 | fL | ||||||||||
| 568 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 11.98 | H | 3.8 - 10.7 | GI/L | |||||||||
| 569 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 9.38 | H | 1.96 - 7.23 | GI/L | |||||||||
| 570 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.49 | 0.8 - 3 | GI/L | ||||||||||
| 571 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.88 | 0.12 - 0.92 | GI/L | ||||||||||
| 572 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.18 | 0 - 0.57 | GI/L | ||||||||||
| 573 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||||
| 574 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 78.4 | H | 40.5 - 75 | % | |||||||||
| 575 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 12.4 | L | 15.4 - 48.5 | % | |||||||||
| 576 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.3 | 2.6 - 10.1 | % | ||||||||||
| 577 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.5 | 0 - 6.8 | % | ||||||||||
| 578 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||||
| 579 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 465 | H | 130 - 394 | GI/L | |||||||||
| 580 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 581 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 582 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 583 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 584 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 585 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 586 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 587 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 588 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 589 | CZ100222004 | Male | Screening | Mar 3, 2026 12:10 PM | 6227810901 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 158 | cm | ||||||||||
| 590 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||||
| 591 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.9 | 0 - 6.2 | umol/L | ||||||||||
| 592 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Alkaline Phosphatase | 78 | 40 - 129 | U/L | ||||||||||
| 593 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | ALT (SGPT) | 69 | H | 5 - 48 | U/L | |||||||||
| 594 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | AST (SGOT) | 33 | 8 - 40 | U/L | ||||||||||
| 595 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | GGT | 38 | 10 - 61 | U/L | ||||||||||
| 596 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | LDH | 213 | 53 - 234 | U/L | ||||||||||
| 597 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Urea Nitrogen | 8.9 | H | 1.4 - 8.6 | mmol/L | |||||||||
| 598 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 105 | 40 - 110 | umol/L | ||||||||||
| 599 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Serum Glucose | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||||
| 600 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Serum Uric Acid | 414 | 125 - 488 | umol/L | ||||||||||
| 601 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | ||||||||||
| 602 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Phosphorus | 1.17 | 0.71 - 1.65 | mmol/L | ||||||||||
| 603 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Total Protein | 70 | 61 - 84 | g/L | ||||||||||
| 604 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||||
| 605 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Creatine Kinase | 157 | 39 - 308 | U/L | ||||||||||
| 606 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 607 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||||
| 608 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Serum Bicarbonate | 25.4 | 19.3 - 29.3 | mmol/L | ||||||||||
| 609 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||||
| 610 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CHEMISTRY PANEL | Magnesium | 0.74 | 0.66 - 1.07 | mmol/L | ||||||||||
| 611 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 80 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 612 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 613 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 138 | 127 - 181 | g/L | ||||||||||
| 614 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.39 - 0.54 | |||||||||||
| 615 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | 4.5 - 6.4 | TI/L | ||||||||||
| 616 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 617 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 618 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||||
| 619 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.87 | 3.8 - 10.7 | GI/L | ||||||||||
| 620 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.24 | 1.96 - 7.23 | GI/L | ||||||||||
| 621 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.46 | 0.91 - 4.28 | GI/L | ||||||||||
| 622 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.34 | 0.12 - 0.92 | GI/L | ||||||||||
| 623 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.79 | R | H | 0 - 0.57 | GI/L | ||||||||
| 624 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||||
| 625 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 38.2 | R | L | 40.5 - 75 | % | ||||||||
| 626 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 41.9 | 15.4 - 48.5 | % | ||||||||||
| 627 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.7 | 2.6 - 10.1 | % | ||||||||||
| 628 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 13.5 | R | H | 0 - 6.8 | % | ||||||||
| 629 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||||
| 630 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 302 | 140 - 400 | GI/L | ||||||||||
| 631 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 632 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Reactive | Ref Rng :$Non Reactive | |||||||||||
| 633 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 634 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 635 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 636 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 637 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 638 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 639 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Test group cancelled: No specimen received | ||||||||||||
| 640 | CZ100222003 | Male | Screening | Mar 2, 2026 11:00 AM | 6227810899 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 641 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 642 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 643 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 644 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 18-Feb-2026 | |||||||||||
| 645 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 07:39 | |||||||||||
| 646 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 647 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | INFLAMED AREA | Inflamed area? | No | ||||||||||||
| 648 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 649 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 650 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 20-Feb-2026 | ||||||||||||
| 651 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 652 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 653 | CZ100222001 | Male | Biopsy | Feb 18, 2026 12:00 AM | 6227323286 | ULCERATED AREA | Is biopsy site ulcerated? | No | ||||||||||||
| 654 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 655 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 656 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 657 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 11-Feb-2026 | |||||||||||
| 658 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 14:38 | |||||||||||
| 659 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 660 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 661 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 662 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 663 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 13-Feb-2026 | ||||||||||||
| 664 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 665 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 666 | CZ100222003 | Male | Biopsy | Feb 11, 2026 12:00 AM | 6227323287 | ULCERATED AREA | Is biopsy site ulcerated? | Yes | ||||||||||||
| 667 | CZ100222002 | Male | Stool Pathogens | Jan 23, 2026 10:10 AM | 6227323277 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 668 | CZ100222002 | Male | Stool Pathogens | Jan 23, 2026 10:10 AM | 6227323277 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 669 | CZ100222002 | Male | Stool Pathogens | Jan 23, 2026 10:10 AM | 6227323277 | OVA AND PARASITES 1 | Concentrate Exam | Test group cancelled: No specimen received | ||||||||||||
| 670 | CZ100222002 | Male | Stool Pathogens | Jan 23, 2026 10:10 AM | 6227323277 | OVA AND PARASITES 1 | Smear for Microsporidia | Test group cancelled: No specimen received | ||||||||||||
| 671 | CZ100222002 | Male | Stool Pathogens | Jan 23, 2026 10:10 AM | 6227323277 | OVA AND PARASITES 1 | Modified acid-fast stain | Test group cancelled: No specimen received | ||||||||||||
| 672 | CZ100222002 | Male | Stool Pathogens | Jan 23, 2026 10:10 AM | 6227323277 | OVA AND PARASITES 2 | Trichrome Smear | Test group cancelled: No specimen received | ||||||||||||
| 673 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||||
| 674 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.9 | 0 - 6.2 | umol/L | ||||||||||
| 675 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Alkaline Phosphatase | 55 | 40 - 129 | U/L | ||||||||||
| 676 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | ALT (SGPT) | 25 | 5 - 48 | U/L | ||||||||||
| 677 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||||
| 678 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | GGT | 12 | 10 - 61 | U/L | ||||||||||
| 679 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | LDH | 190 | 53 - 234 | U/L | ||||||||||
| 680 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Urea Nitrogen | 8.5 | 1.4 - 8.6 | mmol/L | ||||||||||
| 681 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 115 | H | 40 - 110 | umol/L | |||||||||
| 682 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Serum Glucose | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||||
| 683 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Serum Uric Acid | 337 | 125 - 488 | umol/L | ||||||||||
| 684 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Calcium (EDTA) | 2.44 | 2.07 - 2.64 | mmol/L | ||||||||||
| 685 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Phosphorus | 0.86 | 0.71 - 1.65 | mmol/L | ||||||||||
| 686 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||||
| 687 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||||
| 688 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Creatine Kinase | 144 | 39 - 308 | U/L | ||||||||||
| 689 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||||
| 690 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | ||||||||||
| 691 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Serum Bicarbonate | 27.5 | 19.3 - 29.3 | mmol/L | ||||||||||
| 692 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||||
| 693 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CHEMISTRY PANEL | Magnesium | 0.75 | 0.66 - 1.07 | mmol/L | ||||||||||
| 694 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | CKD-EPI 2021 | CKD-EPI 2021 Without Race | 72 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 695 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 696 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 136 | 127 - 181 | g/L | ||||||||||
| 697 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.39 - 0.54 | |||||||||||
| 698 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.5 - 6.4 | TI/L | ||||||||||
| 699 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 700 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 701 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | ||||||||||
| 702 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.82 | 3.8 - 10.7 | GI/L | ||||||||||
| 703 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.49 | 1.96 - 7.23 | GI/L | ||||||||||
| 704 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.54 | 0.91 - 4.28 | GI/L | ||||||||||
| 705 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.41 | 0.12 - 0.92 | GI/L | ||||||||||
| 706 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.34 | 0 - 0.57 | GI/L | ||||||||||
| 707 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||||
| 708 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 42.7 | 40.5 - 75 | % | ||||||||||
| 709 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 43.7 | 15.4 - 48.5 | % | ||||||||||
| 710 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.0 | 2.6 - 10.1 | % | ||||||||||
| 711 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 5.9 | 0 - 6.8 | % | ||||||||||
| 712 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||||
| 713 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 224 | 140 - 400 | GI/L | ||||||||||
| 714 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 715 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEPATITIS B SURFACE AB NON-US | Anti-HBs II QUAL | Reactive | Ref Rng :$Non Reactive | |||||||||||
| 716 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 717 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 718 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 719 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 720 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 721 | CZ100222002 | Male | Screening | Jan 23, 2026 10:00 AM | 6227323268 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 722 | CZ100222001 | Male | Stool Pathogens | R | Jan 15, 2026 4:55 PM | 6227323276 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Test group cancelled: Specimen received beyond stability | |||||||||||
| 723 | CZ100222001 | Male | Stool Pathogens | R | Jan 15, 2026 4:55 PM | 6227323276 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Test group cancelled: Specimen received beyond stability | |||||||||||
| 724 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Total Bilirubin | <3 | L | Result verified by repeat analysis | 3 - 21 | umol/L | ||||||||
| 725 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.4 | 0 - 6.2 | umol/L | ||||||||||
| 726 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Alkaline Phosphatase | 140 | H | 40 - 129 | U/L | |||||||||
| 727 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | ALT (SGPT) | 23 | 5 - 48 | U/L | ||||||||||
| 728 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | AST (SGOT) | 28 | 8 - 40 | U/L | ||||||||||
| 729 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | GGT | 136 | H | 10 - 61 | U/L | |||||||||
| 730 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | LDH | 186 | 53 - 234 | U/L | ||||||||||
| 731 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Urea Nitrogen | 3.9 | 1.4 - 8.6 | mmol/L | ||||||||||
| 732 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 78 | 40 - 110 | umol/L | ||||||||||
| 733 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Serum Glucose | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||||
| 734 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Serum Uric Acid | 408 | 125 - 488 | umol/L | ||||||||||
| 735 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Calcium (EDTA) | 2.31 | 2.07 - 2.64 | mmol/L | ||||||||||
| 736 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Phosphorus | 1.13 | 0.71 - 1.65 | mmol/L | ||||||||||
| 737 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Total Protein | 77 | 61 - 84 | g/L | ||||||||||
| 738 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Albumin-BCG | 41 | 33 - 49 | g/L | ||||||||||
| 739 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Creatine Kinase | 131 | 39 - 308 | U/L | ||||||||||
| 740 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 741 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||||
| 742 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Serum Bicarbonate | 23.1 | 19.3 - 29.3 | mmol/L | ||||||||||
| 743 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||||
| 744 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CHEMISTRY PANEL | Magnesium | 0.82 | 0.66 - 1.07 | mmol/L | ||||||||||
| 745 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | CKD-EPI 2021 | CKD-EPI 2021 Without Race | 111 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 746 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 747 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 85 | L | 127 - 181 | g/L | |||||||||
| 748 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.30 | L | 0.39 - 0.54 | ||||||||||
| 749 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.1 | L | 4.5 - 6.4 | TI/L | |||||||||
| 750 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 21 | L | 26 - 34 | pg | |||||||||
| 751 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Microcytic | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 752 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Anisocytosis | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 753 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 74 | L | 79 - 96 | fL | |||||||||
| 754 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 15.03 | H | 3.8 - 10.7 | GI/L | |||||||||
| 755 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 11.38 | H | 1.96 - 7.23 | GI/L | |||||||||
| 756 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.59 | 0.91 - 4.28 | GI/L | ||||||||||
| 757 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.82 | 0.12 - 0.92 | GI/L | ||||||||||
| 758 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.13 | 0 - 0.57 | GI/L | ||||||||||
| 759 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.11 | 0 - 0.2 | GI/L | ||||||||||
| 760 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 75.7 | H | 40.5 - 75 | % | |||||||||
| 761 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 17.3 | 15.4 - 48.5 | % | ||||||||||
| 762 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.4 | 2.6 - 10.1 | % | ||||||||||
| 763 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.9 | 0 - 6.8 | % | ||||||||||
| 764 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||||
| 765 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 529 | H | 140 - 400 | GI/L | |||||||||
| 766 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 767 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEPATITIS B SURFACE AB NON-US | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 768 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 769 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 770 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 771 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 772 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 773 | CZ100222001 | Male | Screening | Jan 15, 2026 4:45 PM | 6227323266 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative |